✦ LIBER ✦

Rifampicin/pyrazinamide: risk of hepatotoxicity variable?

Book ID: 120855315
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2004
Weight: 139 KB
Volume: &NA;
Category: Article
ISSN: 1173-8324
DOI: 10.2165/00128413-200414540-00036

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Rifampicin/pyrazinamide: increased risk

Rifampicin/pyrazinamide: increased risk of hepatotoxicity vs isoniazid

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 151 KB

Pyrazinamide/rifampicin

✍ Korniłłowicz-Kowalska, Teresa; Rybczyńska, Kamila 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 219 KB

Pyrazinamide/rifampicin

📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 128 KB

Hepatotoxicity of antituberculosis thera

Hepatotoxicity of antituberculosis therapy (rifampicin, isoniazid and pyrazinamide) or viral hepatitis

✍ H. Türktaş; M. Ünsal; N. Tülek; O. Örüç 📂 Article 📅 1994 🏛 Elsevier Science 🌐 English ⚖ 380 KB

Isoniazid/pyrazinamide/rifampicin

📂 Article 📅 2013 🏛 Adis International Limited (now part of Wolters Kl ⚖ 128 KB

Ethambutol/pyrazinamide/rifampicin

✍ Nasouhipur, Hengameh; Banihashemi, Ali; Youssefi Kamangar, Reza; Akhavan-Niaki, 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 219 KB